Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
30,832,276
-
Share change
-
-1,330,565
-
Total reported value
-
$168,344,201
-
Put/Call ratio
-
383%
-
Price per share
-
$5.46
-
Number of holders
-
96
-
Value change
-
-$6,930,688
-
Number of buys
-
43
-
Number of sells
-
35
Institutional Holders of CORBUS PHARMACEUTICALS HLDGS - COM (CRBP) as of Q4 2019
As of 31 Dec 2019,
CORBUS PHARMACEUTICALS HLDGS - COM (CRBP) was held by
96 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
30,832,276 shares.
The largest 10 holders included
ETF MANAGERS GROUP, LLC, BlackRock Inc., Knoll Capital Management, LP, VANGUARD GROUP INC, STATE STREET CORP, FMR LLC, MORGAN STANLEY, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, and D. E. Shaw & Co., Inc..
This page lists
96
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.